ArticleCardiovascular diabetology2026
Association between the triglyceride-glucose-frailty index and all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of the poverty-income ratio.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The association of the combined triglyceride-glucose and frailty index with chronic liver disease: evidence from the CHARLS study.BMC gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundcardiovascular-kidney-metabolic (CKM) syndrome involves complex interplay among metabolic, renal, and cardiovascular dysfunction. The triglyceride-glucose-frailty index (TyGFI) integrates insulin resistance (TyG) and functional decline (frailty), yet its association with mortality in CKM patients remains unexplored. Given that economic resources may influence mortality, whether the poverty–income ratio (PIR) mediates this association warrants investigation.
methodsThis retrospective cohort study drew from the NHANES database for the period from 2005–2018 and included 15,044 participants diagnosed with CKM syndrome. The TyGFI was calculated as the mathematical product of the TyG index [ln (triglycerides × fasting glucose/2)] and the frailty index. Mortality outcomes were ascertained by linking records to the National Death Index and tracking participants until December 31, 2019. Kaplan‒Meier survival curves, Cox regression analysis, restricted cubic spline (RCS), mediation analysis, and subgroup analyses were applied to explore the association between the TyGFI and mortality.
resultsDuring a median observation period of 82 months (IQR: 46–123 months), 1,103 deaths from all causes and 353 cardiovascular deaths occurred. Kaplan‒Meier curves revealed substantially reduced death rates among participants in the lowest TyGFI tertile. Relative to the lowest TyGFI tertile, the highest tertile exhibited more than threefold increased risks for total mortality (HR = 3.14; 95% CI 2.57–3.83; P < 0.001) and cardiovascular mortality (HR = 3.14; 95% CI 2.18–4.52; P < 0.001) following comprehensive adjustment. When analysed continuously, every 1-unit increase in TyGFI corresponded to a 56% increase in the risk for all-cause mortality and a 52% increase in cardiovascular mortality risk. Mediation analysis revealed that PIR partially mediate the TyGFI-mortality association, accounting for 7.66% of all-cause mortality and 8.48% of cardiovascular mortality relationships. Subgroup analysis revealed consistent associations across demographic strata, with a significant interaction for marital status.
conclusionsTyGFI levels in individuals with CKM syndrome are nonlinearly associated with increased all-cause and cardiovascular mortality risk. Additionally, the PIR may partially mediate the TyGFI-mortality relationship, highlighting the possible role of socioeconomic factors. These findings support the use of the TyGFI as a valuable risk assessment tool for mortality evaluation in individuals with CKM syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.